LNK Nighttime Sleep-Aid Tablets: Incorrect Labeling Risk
Recall of Nighttime Sleep-Aid tablets due to incorrect labeling as doxylamine succinate HCl when product is actually doxylamine succinate. No remedy provided.
Lower-risk recall
Labeling: Not Elsewhere Classified: Carton incorrectly identifies product as doxylamine succinate HCl, however the product is doxylamine succinate.
Contact the company
What happened, in plain English
LNK International recalls Nighttime Sleep-Aid tablets that are incorrectly labeled as doxylamine succinate HCl. The product is actually doxylamine succinate, which may cause confusion with a different medication. This recall does not pose a safety risk but requires consumers to check their labels. Read more at govinfonow.com/recall/34379-lnk-nighttime-sleep-aid-tablets-incorrect-labeling-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/34379-lnk-nighttime-sleep-aid-tablets-incorrect-labeling-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-1472-2022
Cite this page
“LNK Nighttime Sleep-Aid Tablets: Incorrect Labeling Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34379-lnk-nighttime-sleep-aid-tablets-incorrect-labeling-risk. Based on FDA recall #D-1472-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1472-2022%22&limit=1).
Why it’s dangerous
The product is labeled as doxylamine succinate HCl but is actually doxylamine succinate. This labeling error could lead to confusion with a different medication, potentially causing incorrect use or medication errors.
Who’s affected
Anyone who owns or uses Nighttime Sleep-Aid tablets distributed by CVS. People most at risk are those who may have taken the product without realizing the labeling error.
How to tell if you have this one
Check for Nighttime Sleep-Aid tablets with the product code P121512 through P129536, distributed by CVS. The product was sold between 2023 and 2025 with specific expiration dates.
- Brand
LNK International- Product
Nighttime Sleep-Aid (doxylamine succinate HCl) tablets, 25 mg, 48-count blisters per carton, Distributed by: CVS- Category
Drug
What to do — step by step
Check Label
Verify the product label to confirm it is doxylamine succinate, not doxylamine succinate HCl.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Product was distributed to one retailer who may have further distributed the product to other distribution sites nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1472-2022 (August 4, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1472-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.